Provided by Tiger Trade Technology Pte. Ltd.

BioRestorative Therapies, Inc.

0.2017
+0.00351.74%
Post-market: 0.1658-0.0359-17.80%19:59 EDT
Volume:489.29K
Turnover:99.19K
Market Cap:5.14M
PE:-0.19
High:0.2099
Open:0.2030
Low:0.2007
Close:0.1983
52wk High:1.86
52wk Low:0.1593
Shares:25.48M
Float Shares:23.76M
Volume Ratio:2.37
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0878
EPS(LYR):-1.5837
ROE:-241.14%
ROA:-118.81%
PB:1.70
PE(LYR):-0.13

Loading ...

BioRestorative presents preclinical exosome data at ISCT 2026 annual meeting

Reuters
·
May 13

BioRestorative Therapies Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
May 08

BioRestorative Therapies reports expanded Phase 2 blinded dataset for BRTX-100

TIPRANKS
·
May 08

BioRestorative reports Phase 2 BRTX-100 data showing 52% hit pain, function endpoint

Reuters
·
May 08

BioRestorative Therapies Inc - 52-Week Cohort Increases to 25 Patients With No Dose-Limiting Toxicity Safety Signals

THOMSON REUTERS
·
May 08

BioRestorative Therapies Inc - 52% of Patients Achieve ≥50% Improvement in Vas Pain and Odi Function at 52 Weeks

THOMSON REUTERS
·
May 08

BioRestorative awards 2025 cash bonuses to CEO, other top executives

Reuters
·
May 02

BioRestorative to present new Phase 2 lumbar disc disease trial data at ISCT 2026

Reuters
·
Apr 30

BioRestorative publishes investor presentation on BRTX-100 stem cell therapy for lumbar disc disease

Reuters
·
Apr 24

BioRestorative Therapies announces partnership with David Goldberg, M.D.

TIPRANKS
·
Apr 21

BioRestorative Therapies Announces Strategic Partnership With Global Dermatology Leader DR. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative Biocosmeceutical Platform

THOMSON REUTERS
·
Apr 21

BioRestorative: Strong Phase 2 BRTX-100 Data and Upcoming 2027 Catalyst Underpin Buy Rating and Attractive Risk‑Reward

TIPRANKS
·
Apr 10

BioRestorative partners with 203 Creates to commercialize biocosmeceutical skincare platform

Reuters
·
Apr 07

BioRestorative Therapies Announces Strategic Collaboration With 203 Creates to Build and Commercialize Biocosmeceutical Platform

THOMSON REUTERS
·
Apr 07

BioRestorative Therapies announces special shareholder meeting on authorized share increase proposal

Reuters
·
Apr 04

BioRestorative Therapies price target lowered to $15 from $18 at Roth Capital

TIPRANKS
·
Apr 02

BRIEF-Biorestorative Therapies Reports Positive Phase 2 Blinded Data For Brtx-100

Reuters
·
Mar 30

BioRestorative Therapies Inc - Reports Phase 2 Data for Brtx-100 With 50%+ Patients Showing >50% Improvement

THOMSON REUTERS
·
Mar 30

BioRestorative Therapies Inc - No Adverse Events Related to Dose-Limiting Toxicities Associated With Hypoxic-Cultured Mesenchymal Stem Cells

THOMSON REUTERS
·
Mar 30

BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

GlobeNewswire
·
Mar 30